AXL regulates mesothelioma proliferation and invasiveness

Oncogene

Volumn 30, Issue 14, 2011, Pages 1643-1652

  Ou, W B ^a   Corson, J M ^a   Flynn, D L ^b   Lu, W P ^b   Wise, S C ^b   Bueno, R ^a   Sugarbaker, D J ^a   Fletcher, J A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Deciphera Pharmaceuticals LLC   (United States)

Author keywords

AXL; invasiveness; mesothelioma; proliferation; receptor tyrosine kinases

Indexed keywords

GROWTH ARREST SPECIFIC PROTEIN 6; PHOSPHOTYROSINE; PROTEIN AXL; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ARTICLE; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL PROLIFERATION; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TUMOR BIOPSY;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXONS; GENE SILENCING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESOTHELIOMA; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PLEURAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE DELETION; SIGNAL TRANSDUCTION;

LENTIVIRUS;

EID: 79953798945     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.555     Document Type: Article

References (43)

1. Burchert A, Attar EC, McCloskey P, Fridell YW, Liu ET. (1998). Determinants for transformation induced by the Axl receptor tyrosine kinase. Oncogene 16: 3177-3187. (Pubitemid 28318789)
2. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ et al. (1994). Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781-1790. (Pubitemid 24163409)
3. Catalano A, Romano M, Martinotti S, Procopio A. (2002). Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Oncogene 21: 2896-2900. (Pubitemid 34499388)
4. Craighead JE, Mossman BT. (1982). The pathogenesis of asbestos-associated diseases. N Engl J Med 306: 1446-1455. (Pubitemid 12121576)
5. Craven RJ, Xu LH, Weiner TM, Fridell YW, Dent GA, Srivastava S et al. (1995). Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 60: 791-797.
6. Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD. (1989). Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74: 940-946. (Pubitemid 19210007)
7. Faber AC, Li D, Song Y, Liang MC, Yeap BY, Bronson RT et al. (2009). Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition. Proc Natl Acad Sci USA 106: 19503-19508.
8. Gschwind A, Fischer OM, Ullrich A. (2004). The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4: 361-370. (Pubitemid 38579482)
9. Harir N, Boudot C, Friedbichler K, Sonneck K, Kondo R, Martin-Lanneree S et al. (2008). Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. Blood 112: 2463-2473.
10. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N et al. (2003). PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299: 708-710. (Pubitemid 36159485)
11. Holland SJ, Powell MJ, Franci C, Chan EW, Friera AM, Atchison RE et al. (2005). Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res 65: 9294-9303. (Pubitemid 41507996)
12. Ito T, Ito M, Naito S, Ohtsuru A, Nagayama Y, Kanematsu T et al. (1999). Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. Thyroid 9: 563-567. (Pubitemid 29296118)
13. Jacob AN, Kalapurakal J, Davidson WR, Kandpal G, Dunson N, Prashar Y et al. (1999). A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145. Cancer Detect Prev 23: 325-332. (Pubitemid 29311594)
14. Jagadeeswaran R, Ma PC, Seiwert TY, Jagadeeswaran S, Zumba O, Nallasura V et al. (2006). Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res 66: 352-361. (Pubitemid 43166042)
15. Janne PA, Taffaro ML, Salgia R, Johnson BE. (2002). Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Res 62: 5242-5247. (Pubitemid 35024597)
16. Janssen JW, Schulz AS, Steenvoorden AC, Schmidberger M, Strehl S, Ambros PF et al. (1991). A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene 6: 2113-2120. (Pubitemid 21924053)
17. Klominek J, Baskin B, Liu Z, Hauzenberger D. (1998). Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer 76: 240-249. (Pubitemid 28180379)
18. Lay JD, Hong CC, Huang JS, Yang YY, Pao CY, Liu CH et al. (2007). Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res 67: 3878-3887.
19. Lee TC, Zhang Y, Aston C, Hintz R, Jagirdar J, Perle MA et al. (1993). Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res 53: 2858-2864. (Pubitemid 23180528)
20. Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J et al. (2009). Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene 28: 3442-3455.
21. Mahadevan D, Cooke L, Riley C, Swart R, Simons B, Della CK et al. (2007). A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene 26: 3909-3919. (Pubitemid 46884299)
22. Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, Hung MC. (2002). Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res 8: 361-367. (Pubitemid 34193951)
23. Mukohara T, Civiello G, Davis IJ, Taffaro ML, Christensen J, Fisher DE et al. (2005). Inhibition of the met receptor in mesothelioma. Clin Cancer Res 11: 8122-8130. (Pubitemid 41698757)
24. O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C et al. (1991). axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11: 5016-5031. (Pubitemid 21895263)
25. Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M et al. (1999). VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothe-lioma tumours. Br J Cancer 81: 54-61. (Pubitemid 29415491)
26. Pache JC, Janssen YM, Walsh ES, Quinlan TR, Zanella CL, Low RB et al. (1998). Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am J Pathol 152: 333-340. (Pubitemid 28106377)
27. Pass HI, Liu Z, Wali A, Bueno R, Land S, Lott D et al. (2004). Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res 10: 849-859. (Pubitemid 38198883)
28. Pass HI, Mew DJ, Carbone M, Matthews WA, Donington JS, Baserga R et al. (1996). Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor. Cancer Res 56: 4044-4048. (Pubitemid 26284758)
29. Quong RY, Bickford ST, Ing YL, Terman B, Herlyn M, Lassam NJ. (1994). Protein kinases in normal and transformed melanocytes. Melanoma Res 4: 313-319. (Pubitemid 24323266)
30. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R et al. (2001). KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61: 8118-8121. (Pubitemid 33091601)
31. Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I et al. (2001). The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1: 63-72. (Pubitemid 33586069)
32. Shieh YS, Lai CY, Kao YR, Shiah SG, Chu YW, Lee HS et al. (2005). Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia 7: 1058-1064.
33. Sordella R, Bell DW, Haber DA, Settleman J. (2004). Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163-1167. (Pubitemid 39100331)
34. Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C et al. (1995). The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80: 661-670.
35. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R et al. (2007). Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318: 287-290. (Pubitemid 47574858)
36. Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G et al. (2001). Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193: 468-475. (Pubitemid 32266815)
37. Tai KY, Shieh YS, Lee CS, Shiah SG, Wu CW. (2008). Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1. Oncogene 27: 4044-4055.
38. Tolnay E, Kuhnen C, Wiethege T, Konig JE, Voss B, Muller KM. (1998). Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. J Cancer Res Clin Oncol 124: 291-296. (Pubitemid 28332909)
39. Tsao AS, He D, Saigal B, Liu S, Lee JJ, Bakkannagari S et al. (2007). Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion. Mol Cancer Ther 6: 1962-1972. (Pubitemid 47052486)
40. Varnum BC, Young C, Elliott G, Garcia A, Bartley TD, Fridell YW et al. (1995). Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 373: 623-626.
41. Wimmel A, Glitz D, Kraus A, Roeder J, Schuermann M. (2001). Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer 37: 2264-2274. (Pubitemid 33001299)
42. Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D et al. (2005). Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res 11: 4305-4315. (Pubitemid 40825617)
43. Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM et al. (2007). Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene 26: 1459-1467.